Key points are not available for this paper at this time.
To describe the prevalence, demographic characteristics, and cognitive function of individuals who believe that selective serotonin reuptake inhibitor (SSRI) use caused or exacerbated symptoms of REM-sleep behavior disorder (RBD) compared to idiopathic RBD (iRBD) in the North American Prodromal Synucleinopathy (NAPS) consortium registry.
Reddy et al. (Tue,) studied this question.